Star Combo Pharma Ltd
ASX:S66

Watchlist Manager
Star Combo Pharma Ltd Logo
Star Combo Pharma Ltd
ASX:S66
Watchlist
Price: 0.135 AUD Market Closed
Market Cap: 18.2m AUD
Have any thoughts about
Star Combo Pharma Ltd?
Write Note

Intrinsic Value

S66 doesn't have a meaningful market cap.

The intrinsic value of one S66 stock under the Base Case scenario is 0.133 AUD. Compared to the current market price of 0.135 AUD, Star Combo Pharma Ltd is Overvalued by 1%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

S66 Intrinsic Value
0.133 AUD
Overvaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Star Combo Pharma Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
S66
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for S66 cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about S66?
Bearish
Neutral
Bullish

Fundamental Analysis

0.135 AUD
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Star Combo Pharma Ltd
AU
Consumer products
Market Cap
18.2m AUD
IPO
May 16, 2018
Employees
-
Australia
Market Cap
18.2m AUD
Industry
Consumer products
IPO
May 16, 2018
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Star Combo Pharma Ltd

Provide an overview of the primary business activities
of Star Combo Pharma Ltd.

What unique competitive advantages
does Star Combo Pharma Ltd hold over its rivals?

What risks and challenges
does Star Combo Pharma Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Star Combo Pharma Ltd.

Provide P/S
for Star Combo Pharma Ltd.

Provide P/E
for Star Combo Pharma Ltd.

Provide P/OCF
for Star Combo Pharma Ltd.

Provide P/FCFE
for Star Combo Pharma Ltd.

Provide P/B
for Star Combo Pharma Ltd.

Provide EV/S
for Star Combo Pharma Ltd.

Provide EV/GP
for Star Combo Pharma Ltd.

Provide EV/EBITDA
for Star Combo Pharma Ltd.

Provide EV/EBIT
for Star Combo Pharma Ltd.

Provide EV/OCF
for Star Combo Pharma Ltd.

Provide EV/FCFF
for Star Combo Pharma Ltd.

Provide EV/IC
for Star Combo Pharma Ltd.

Compare the intrinsic valuations
of Star Combo Pharma Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Star Combo Pharma Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Star Combo Pharma Ltd compared to its peers.

Compare the P/E ratios
of Star Combo Pharma Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Star Combo Pharma Ltd with its peers.

Analyze the financial leverage
of Star Combo Pharma Ltd compared to its main competitors.

Show all profitability ratios
for Star Combo Pharma Ltd.

Provide ROE
for Star Combo Pharma Ltd.

Provide ROA
for Star Combo Pharma Ltd.

Provide ROIC
for Star Combo Pharma Ltd.

Provide ROCE
for Star Combo Pharma Ltd.

Provide Gross Margin
for Star Combo Pharma Ltd.

Provide Operating Margin
for Star Combo Pharma Ltd.

Provide Net Margin
for Star Combo Pharma Ltd.

Provide FCF Margin
for Star Combo Pharma Ltd.

Show all solvency ratios
for Star Combo Pharma Ltd.

Provide D/E Ratio
for Star Combo Pharma Ltd.

Provide D/A Ratio
for Star Combo Pharma Ltd.

Provide Interest Coverage Ratio
for Star Combo Pharma Ltd.

Provide Altman Z-Score Ratio
for Star Combo Pharma Ltd.

Provide Quick Ratio
for Star Combo Pharma Ltd.

Provide Current Ratio
for Star Combo Pharma Ltd.

Provide Cash Ratio
for Star Combo Pharma Ltd.

What is the historical Revenue growth
over the last 5 years for Star Combo Pharma Ltd?

What is the historical Net Income growth
over the last 5 years for Star Combo Pharma Ltd?

What is the current Free Cash Flow
of Star Combo Pharma Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Star Combo Pharma Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Star Combo Pharma Ltd

Current Assets 18.4m
Cash & Short-Term Investments 7.4m
Receivables 4.5m
Other Current Assets 6.5m
Non-Current Assets 24.5m
PP&E 23.1m
Intangibles 677.2k
Other Non-Current Assets 684.7k
Current Liabilities 4.9m
Accounts Payable 4m
Accrued Liabilities 437.5k
Other Current Liabilities 385.4k
Non-Current Liabilities 4.6m
Long-Term Debt 3.9m
Other Non-Current Liabilities 747.9k
Efficiency

Earnings Waterfall
Star Combo Pharma Ltd

Revenue
26.3m AUD
Cost of Revenue
-20.3m AUD
Gross Profit
6m AUD
Operating Expenses
-4.8m AUD
Operating Income
1.2m AUD
Other Expenses
-436.4k AUD
Net Income
747.3k AUD

Free Cash Flow Analysis
Star Combo Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

S66 Profitability Score
Profitability Due Diligence

Star Combo Pharma Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
ROIC is Increasing
Positive Gross Profit
Positive 1-Year Revenue Growth
35/100
Profitability
Score

Star Combo Pharma Ltd's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

S66 Solvency Score
Solvency Due Diligence

Star Combo Pharma Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Low D/E
Negative Net Debt
53/100
Solvency
Score

Star Combo Pharma Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

S66 Price Targets Summary
Star Combo Pharma Ltd

There are no price targets for S66.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for S66?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for S66 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one S66 stock?

The intrinsic value of one S66 stock under the Base Case scenario is 0.133 AUD.

Is S66 stock undervalued or overvalued?

Compared to the current market price of 0.135 AUD, Star Combo Pharma Ltd is Overvalued by 1%.

Back to Top